These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 23565620)

  • 1. What about us? Recent advances in the treatment of chronic hepatitis C threaten to leave some parts of the world behind.
    Ahmed F
    J Viral Hepat; 2013 May; 20(5):367-8. PubMed ID: 23565620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious diseases. First specific drugs raise hopes for hepatitis C.
    Enserink M
    Science; 2011 Apr; 332(6026):159-60. PubMed ID: 21474720
    [No Abstract]   [Full Text] [Related]  

  • 3. The changing face of hepatitis C in the new era of direct-acting antivirals.
    Soriano V; Labarga P; Fernández-Montero JV; Benito JM; Poveda E; Rallon N; Sánchez C; Vispo E; Barreiro P
    Antiviral Res; 2013 Jan; 97(1):36-40. PubMed ID: 23147192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of direct-acting antiviral therapy in chronic hepatitis C.
    Gellad ZF; Reed SD; Muir AJ
    Antivir Ther; 2012; 17(6 Pt B):1189-99. PubMed ID: 23186646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Approach to the treatment-experienced patient with hepatitis C virus genotype 1 infection.
    Flemming JA; Terrault NA
    Infect Dis Clin North Am; 2012 Dec; 26(4):903-15. PubMed ID: 23083823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].
    Zuckerman E; Safadi R; Oren R; Shibolet O; Baruch Y; Bruck R; Lurei Y; Kaspa RT; Abu-Mouch S; Shouval D; Ben-Ari Z;
    Harefuah; 2012 Dec; 151(12):709-14, 719. PubMed ID: 23330266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New triple therapy in chronic hepatitis C. Increased patient chances].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Sep; 153(39):20. PubMed ID: 21991830
    [No Abstract]   [Full Text] [Related]  

  • 8. Future of hepatitis C therapy: development of direct-acting antivirals.
    Dore GJ; Matthews GV; Rockstroh J
    Curr Opin HIV AIDS; 2011 Nov; 6(6):508-13. PubMed ID: 21897228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis C in 2011.
    Williams R; Khan AG
    J Ayub Med Coll Abbottabad; 2010; 22(3):1-2. PubMed ID: 22338403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted therapies for hepatitis C reach the clinic.
    Erdmann J
    Chem Biol; 2012 Apr; 19(4):433-4. PubMed ID: 22520745
    [No Abstract]   [Full Text] [Related]  

  • 11. Provisional guidance on the use of hepatitis C virus protease inhibitors for treatment of hepatitis C in HIV-infected persons.
    Thomas DL; Bartlett JG; Peters MG; Sherman KE; Sulkowski MS; Pham PA
    Clin Infect Dis; 2012 Apr; 54(7):979-83. PubMed ID: 22173234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will IL28B polymorphism remain relevant in the era of direct-acting antiviral agents for hepatitis C virus?
    Thompson AJ; McHutchison JG
    Hepatology; 2012 Jul; 56(1):373-81. PubMed ID: 22511355
    [No Abstract]   [Full Text] [Related]  

  • 13. Future perspectives: towards interferon-free regimens for HCV.
    Gane E
    Antivir Ther; 2012; 17(6 Pt B):1201-10. PubMed ID: 23186654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A new era in therapy of hepatitis C: "the therapy can now be individualized" (interview by Dr. med. Dirk Einecke)].
    Manns M
    MMW Fortschr Med; 2011 Jul; 153(29-31):17. PubMed ID: 21830729
    [No Abstract]   [Full Text] [Related]  

  • 15. New direct-acting antiviral agents for the treatment of hepatitis C virus infection and perspectives.
    Welsch C; Jesudian A; Zeuzem S; Jacobson I
    Gut; 2012 May; 61 Suppl 1():i36-46. PubMed ID: 22504918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailoring the length of antiviral treatment for hepatitis C.
    Mangia A; Andriulli A
    Gut; 2010 Jan; 59(1):1-5. PubMed ID: 20007952
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatitis C: An Eastern Perspective.
    Dan YY; Lim SG
    Gastroenterol Clin North Am; 2015 Dec; 44(4):793-805. PubMed ID: 26600220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3 infection?
    Lagging M; Alsiö S; Hellstrand K; Norkrans G;
    J Hepatol; 2011 Apr; 54(4):835-6; author reply 836-7. PubMed ID: 21145838
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase 3 study results released for telaprevir and HCV.
    AIDS Patient Care STDS; 2010 Oct; 24(10):685-6. PubMed ID: 20945535
    [No Abstract]   [Full Text] [Related]  

  • 20. Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection.
    Trembling PM; Tanwar S; Dusheiko GM
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):269-79. PubMed ID: 22397560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.